Delays won’t matter if funding is secured through year end and with CTC read out 3 weeks away. While the CTC read out will likely not be announced with only one patient enrolled, that data will be available to potential buyers with a signed NDA.

I am hopeful tomorrow comes with insight into more funding. My wild guess is that Bruce Patterson and IncellDX have much larger roles to play in the evolution of CYDY. It’s unusual for someone who is not an employee of a company to be a featured speaker at the SH meeting and the last CC. I imagine he will be front stage tomorrow as well. I don’t know what his future role will be but I wouldn’t be surprised if he was brought into CYDY management team (potentially even CEO) especially if it comes with a bridge loan from incelldx (private company with a lot of financial freedom) that is repaid either by BLA milestone payment or with future revenues from prognostic test. The prognostic test would fit perfectly in Incelldx’s portfolio.

Anyways, this is all speculation. I just hope tomorrow is NP yelling at us investors for questioning his infallible prophecies again. Tomorrow will tell us how painful the next couple months will be. Also hoping for much more detail into the FDA delays as well.